Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration
2019 · Ophthalmology · 491 citations
https://doi.org/10.1016/j.ophtha.2019.07.011
R
Ramiro Ribeiro
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
51
Papers
1.9K
Citations
18
h-index
21
i10-index
Ramiro Ribeiro is an academic researcher from Apellis Pharmaceuticals (United States). The author has contributed to research in topics: Retinal Diseases and Treatments & Retinal Development and Disorders & Retinal Imaging and Analysis. The author has an h-index of 18, co-authored 44 publications.
Papers by this author
worksAssociation of complement C3 inhibitor pegcetacoplan with reduced photoreceptor degeneration beyond areas of geographic atrophy
2022 · Scientific Reports · 37 citations
https://doi.org/10.1038/s41598-022-22404-9
Progression of Geographic Atrophy
2023 · Ophthalmology Science · 17 citations
https://doi.org/10.1016/j.xops.2023.100318
Pharmacokinetic/pharmacodynamic analysis of geographic atrophy lesion area in patients receiving pegcetacoplan treatment or sham
2024 · CPT Pharmacometrics & Systems Pharmacology · 2 citations
https://doi.org/10.1002/psp4.13264
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat